例黃疸原因待查患者臨床表現(xiàn)及肝穿病理特點(diǎn)分析_第1頁(yè)
例黃疸原因待查患者臨床表現(xiàn)及肝穿病理特點(diǎn)分析_第2頁(yè)
免費(fèi)預(yù)覽已結(jié)束,剩余1頁(yè)可下載查看

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1718中國(guó)現(xiàn)代醫(yī)學(xué)雜志Vol.17No.20079Sep.文章 1005-8982(2007)18-2181-

ysisof214casesofclinicalmanifestationandhistopathologicalfeaturesinpercutaneousliverbiopsyfortheictericwithunrecognized(1.DepartmentofSynthetic,YouanHospital,CapitalMedicalUniversity,Beijing100069,P.R.China;2.DepartmentofClinicalMedicine,ChaoyangHospital,CapitalMedicineUniversity,Beijing100020,P.R.China):Objective】Tostudytheclinicalandhistopathologicalspecialityof214ictericpatientswhoseviralindexeswerenegativewhenadmittedtothehospital. Methods】214patientswithjaundicewhoseviralindexeswerenegativewereselected.Webothwrotedownandyzedtheirsymptomsandphysicalsigns,resultsofliverfunction,immunodetectionandbloodroutine.Results】Thepatientssufferedfromthesediseasesincludingviralhepatitis,thedrug-inducedliverdisease,autoimmuneliverdisease,obstructivejaundice,unknownreason,acuiv-erfailure,cholestatichepatitisandacuteadiposishepaticaongestationalperiodwhohavemoresymptomsthanotherdiseases(﹥60%).ThepatientssufferedfromthesediseasesincludingPBC,alcoholicliverdisease,unknownreasondiseasesandacuiverfailurewhohadmorephysicalsignsthanotherdiseases.Viralhepatitis,drug-inducedliverdisease,unknownreasondiseases,acuiverfailureandacuteadiposishepaticaongestationalperiodhadsignifi-cantabnormalliverfunction.ThemeanvaluesofESR(erythrocytesedimentationrate)ofthesediseasessuchasviralhepatitis,alcoholicliverdisease,hepatolenticulardegeneration,pancreaticcancer,acuteadiposishepaticaongesta-tionalperiodwerehigherthanotherdiseases;themeanvaluesofAFP(alphafetoprotein)ofthepatientssufferedfromhepatomawerehigherthanotherpatients.Conclusions】Somekindsofdiseaseswhicharecommonlyseenareau-toimmuneliverdisease,viralhepatitis,drug-inducedliverdisease,obstructivejaundice,alcoholicliverdisease,con-genitaldisease,theunknownreasondiseaseinsequence.Nospecialcomplaintsbelongtothesediseasesrespective-ly,exceptobstructivejaundicewithpotteryclaysedes.Sometimesageandsexareimportantfactors.Percutaneousneedlebiopsyoftheliverisakindofpotentialexamination,butisnotalmighty,andultrasound(SUV),CT(computedinsomecases.:jaundice;clinicalmanifestation;percutaneousneedlebiopsyoftheliver;correlationCLCNumber:R575 code:A214例黃疸原因待查患者臨床表現(xiàn)龍1,2,(1.首都醫(yī)學(xué)附屬佑安醫(yī)院綜合科,12.首都醫(yī)學(xué)附屬朝陽(yáng)醫(yī)院臨床藥理,1:目的 研究214例入院時(shí)學(xué)指標(biāo)是的黃疸原因待查患者的臨床表現(xiàn)和肝穿病理特點(diǎn)方法選擇學(xué)指標(biāo)的黃疸待查患者 將他們的癥狀體征肝功能免疫學(xué)以及血常規(guī)依據(jù)病種分列成表并加以分析結(jié) 性肝炎藥物性肝病自身免疫性肝病梗阻性黃疸原因不明黃疸暴發(fā)性肝衰竭以及Receiveddate:Sep.14,中國(guó)現(xiàn)代醫(yī)學(xué)雜 第17。妊娠急性脂肪肝患者的不適主訴較多(>60)。PC性肝病原因不明黃疸和暴發(fā)性肝衰竭患者的陽(yáng)性體征較多(>60) 性肝炎藥物性肝病原因不明黃疸暴發(fā)性肝衰竭以及妊娠急性脂肪肝患者的肝功能明顯異常。性肝炎性肝病肝豆?fàn)詈俗冃砸群腿焉锛毙灾靖位颊叩难林得黠@升高,P的明顯升高僅見(jiàn)于肝癌患者結(jié)論 依據(jù)疾病出現(xiàn)的頻率,從高到低依次是自身免疫性肝病性肝炎藥物性肝病梗阻性黃疸性肝病性疾病不明原因黃疸除梗阻性黃疸有陶土樣便以外,消化系統(tǒng)常見(jiàn)的不適癥狀多數(shù)是非特異的和有時(shí)是重要的因素肝穿活檢是一項(xiàng)重要的檢查,超聲CT肝血管造影、RCP(逆行膽胰管造影)同樣是必要的檢查。。 黃疸;臨床表現(xiàn);經(jīng)皮肝穿活檢;相關(guān)性號(hào): R575 文獻(xiàn)標(biāo)識(shí)碼: JaundiceistheresultthatTBIL(totalbilirubin)concentrationinserumisabove1mg/dl,whiakestheworldseeskinandalbugineaoculiturningyellow.Itiseasytoconfuseclinicalworkbecausetherearetoomanyfactorsthatinfluencethelevelofjaundice.Weselectedthepatientsappearedictericwhoserea-sonsofdiseasewereunrecognized,andthenstudytheirclinicalandhistopathologicalspecialities.MaterialsandCasesselectionandWecollected214patientsappearedictericwhoseviralindexeswerenegative,whileadmittedtothe

hospital.Allmaterialswerein-patientsfromJune1st,2004toJuly1st,2005inourhospital.Malewas113andfemalewas101.Age:2~89years,themeanage:MethodofsamplesWebothwrotedownandyzedtheirsymp-toms,physicalsigns,resultsofliverfunction,immun-odetectionandbloodroutine.StatisticalFtestwasusedtocomparethemeansofindexesamongthedifferentdiseases.StatisticalysesweredonebySPSS11.5software.Table1Comparisonof214cases′symptoms Jaundice Jaundice NauseaVomitingBellyacheAbdominal Viral60Drug-inducedliver40033980690Obstructive060Alcoholicliver0600636700Unknown77409940Acuiver886622468640330100032320Overlap440200022220Buddy-Chiari220000212220SS-550300032530Dubin-Johnson440000003100Gilbert550000001420Hepatolenticular330100111200Cholestatic662300023430Pancreatic551221022330Malformationofhepatic 11000011100Acuteadiposishepatica 31321122100

vo-gestationalNote:aboutmorethan7kindsofsymptomscouldturnoutinthesediseaseswith*.AIH(autoimmunehepatitis),PBC(primarybiliarycirrhosis),PSC第18 江,等:214例黃疸原因待查患者臨床表現(xiàn)及肝穿病理特點(diǎn)分Table2Comparisonof214cases′conventionalliverfunctions Viralhepatitis#183426±7683171640±972019060±46303589±37019060±54105905 ±44509748±2930963±42127420±78Thedrug-induced97640±3024263480±3261010400±44203670±94027503±98424012 ±58208505±17231044±57813920±64 14767±448313400±810011267±43333899±84116576±70164964 ±531010240±2380446±19722325±178 20680±974014310±743012700±36903540±113019695±7344432970±12042233040±1128013382±5613838±49265260±384

25225±1434115680±342029520±48403875±91324294±11784543040±11064025950±685012962±47532065±167317450±83 9427±37 8530±294118620±59703371±86214620±3921413270±12096019420±673011720±3850491±14329480±92Alcoholicliver23476±1275127248±1436110630±32403670±74116720±54304176 ±732013940±5780324±13382126±384

84740±524607860±294013129±22303587±69311899±6943570450±24178015240±427012740±2360594±3328371±45243740±86320124070±3844016750±26504297±56816840±54705680 ±35603218±567665±23814825±36 15525±47 9890±324018450±34603272±54115685±6824245650±8045022740±592012961±32452861±112416750±54sonGilbertlarAcuteadiposis

12573±732410427±432526017±84564213±124316512±6952349000±6390016670±393010420±2750387±12535850±17610270±349272±263417450±55803720±3184640±19704892±34909640±2130346±12310420±297640±386840±367211740±45203460±49516245±48613604±43608792±2934397±1364732±149650±31 6820±275010420±35803970±82205420±1560413400±8267021740±396010420±1850814±30611530±399470±35 7790±25409740±28603750±4607250±2140408700±4965020450±45709850±1430427±18914720±4512160±48 8750±297013240±47503850±6706720±2250397400±4542019430±436011470±3650659±23424780±7646270±1348028540±895028430±57203920±38023153±9417381600±3682024270±498012760±3580971±32426140±5724720±874018420±673031450±47203820±43021783±7946378420±3953021740±345010750±24801356±47326780±7456 94 520 34 28 4045 154 72 2 283aticaon 30±9464018530±64203950±41012620±5360421640±8737017830±41907460±32701060±32013640±54Note:Suchdiseaseswith#comparedwithotherdiseaseshavesignificantvariantPGeneralTherewere28patientswhosufferedfromhep-atitisE infection,and14patientssufferedfromhepatitisA infection.Intotal,itsratiois42/214.Among51patients,therewere11 swhoseim-munodetectionwereallnegative.Andtheirdiagnosisresultfromhistopathologicalfeatures.ysisof214Fromtable1,wecouldlearnthat:thepatientssufferedfromthesediseasesincludingviralhepatitis,drug-inducedliverdisease,autoimmuneliverdisease(AIH,PBC,SS-syndromeandOverlapsyndrome)[1~3],obstructivejaundice,unknownreason,acu iverfail-ure,cholestatichepatitis,pancreaticcancerandacuteadiposishepaticaongestationalperiodwhohadmoresymptomsthanotherdiseases(≥7/11).Weshouldthinkofobstructivejaundiceifwemeettheelderpa-tientswithfeverandbellyache.Onthecontrary,con-gentaldiseasewilloccurtouswhenthepatientswere

ysisof214casesconentionalliverfunc-Fromtable2,wecouldlearnthat:thepatientssufferedfromthesediseasesincludingviralhepatitis,drug-inducedliverdisease,theunknownreason,a-cuteliverfailureandacuteadiposishepaticaonges-tationalperiodhavesignificantabnormalliverfunc-ysisof214cases′resultsofbloodroutineandAFPFromtable3(omitted),havingcomparedthere-sultsofbloodroutineandAFP,wecouldlearnthat:ThemeanvaluesofESRofthesediseasessuchasvi-ralhepatitis,alcoholicliverdisease,hepatolenticulardegeneration,pancreaticcancer,acuteadiposishepat-icaongestationalperiodwerehigherthanotherdis-eases(AccordingtothemeanvalueofESR,above-mentioneddiseasescomparedwithotherdiseaseshad1717中國(guó)現(xiàn)代醫(yī)學(xué)雜志Table3Correlationbetweendefinitediagnosisandliver CasenumberLiverbiopsynumber9632Overlap42SS-50NotViral4Thedrug-inducedliver8Obstructive0Not0NotAlcoholicliver0Not4InAcuiver82Buddy-Chiari20NotDubin-Johnson42Gilbert52

cuallySUV,CTandMR(magneticresonance)cannotdetectthecalculusinbillarysystemforonetime,sowemustrepeatthesedetection.Jaundiceisaverycommonandsophisticatedsymptom.Bytakingand yzingthesein-patients′datum,wehavegotsomeconclusions.Aboveall,bylistingoutofthereasonsthatcausedjaundice,autoim-muneliverdiseasewasthewinnerwhoseratiowas51/214,whichincludes:AIH,PBC,PSC,SS-syndromeandsoon;therunneruptoautoimmuneliverdiseasewasNo.2-viralhepatitis,anditsratiowas42/214;No.3-thedrug-inducedliverdiseasewhoseratiowas34/214;No.4-obstrustivejaundice,whichcomprisedbenignobstructionandcarcinoma,itsratiowas33/229;No.5-alcoholicliverdisease,congentaldisease[6,7]andtheunknownreasondiseases, allofthemoccu-Hepatolenticulardegen-

Not

pied12/214;nexttothemwasacutehepaticCholestatic Pancreatic Not

whoseratiowas8/214.Besidesthem,therewereex-ceptionalkindsofdiseases,suchasmalformationmbloodAcuteadiposishepaticaongestationalperiod

Not

hepaticbloodvesselandacuteadiposishepaticaongestationalperiod.Wecanexplainitinfullasfollow:Theworldoftenseesviralhepatitis,whileviralmarkNote:theliverbiopsyofsomediseaseswith*havenodirectrelationwiththeirsignificantvariant,P<0.05).ThemeanvaluesofAFPofthepatientssufferedfromhepatomawerehigherthanotherpatients(AccordingtothemeanvalueofAFP,mostdiseaseshadnosignificantvariantexceptforhepatoma,P<0.05).phFromtable4(omitted),havingcompared214cas-esphysicalsigns,wecouldlearnthat:thepatientssufferedfromthesediseasesincludingPBC,alcoholicliverdisease,unknownreasondiseases,acu failureandacuteadiposishepaticaongestationalpe-riodwhohadmorephysicalsignsthanotherdiseases(≥6/9)(Morethan6kindsofphysicalsignscouldbefoundoutinabove-mentioneddiseases).Correlationbetweendiagnosisandpercuta-neousneedlebiopsyofliverDiagnosisFromtable3,wecanlearnthat:ingeneral,liverbiopsycanhelpustogettherightofsomediseases[2,4],exceptforsomediseaseincludingPSCandmalformationofhepaticbloodvessel[5].Oc-

couldnotbefoundoutduringtheearlyperiod.Some-timesweneedrepeattheviraltestsinorderthatwearesuretoexcludethem.Formostpatientssufferedfromautoimmuneliverdiseasearefemale,wemustperformtheautologousantibodytests,ESRandotherimmunodetection,whichcanhelpusgetdefinitediag-nosissometimes[1,8].Ifwemeetsomepregnantwomenorjustafterpregnancy,withseveresymptoms,thepossibilityofacuteadiposishepaticaongestationalperiodshouldoccurtous.Fromtheliverfunctiontestresults,thepatientssufferedfromviralhepatitis,thedrug-inducedliverdisease,theunknownreasondis-easesandacuteliverfailure,whosemeanvaluewashigherthanotherdiseases,especiallythefiveclinicalindications,namelyALT,AST,TBIL,ALPandGGT.Percutaneousneedlebiopsyoftheliverplaysaveryessentialrole gnosis,itcanhelpusgettherightreasonsandconditionsofmostliverdiseases.Butitisnotalmighty,wemustcollectdiversityclinicaldatumbeforewegetthefinaldiagnosis.Let`slookatafewcases,thepatientssufferedfromthedrug-induced(Continuedonpage不盡相同,結(jié)果也缺乏可比性。本研究的的結(jié)果是第一個(gè)基于本方法的,小鼠肝臟硫酸乙酰肝素的生參考文獻(xiàn)KINOSHITAA,SUGAHARA sofJapaneseCarbohydrateSymposium,August5-7,1997,Nishi-nomiya,Japan,p.106.SUGAHARAK,YAMADAS,YOSHIDAK,etal.Anovelfatedstructureinthecarbohydrate-proteinlinkageregionisolatedfromporcineintestinalheparin[J].J.Biol.Chem,1992,267,1528-1533.SALMIVIRTAM,LIDHOLTK,LINDAHLU.Heparansulfate:pieceofinformation[J].FASEBJ,1996,10:1270-BERNFIELDM,GOTTEM,PARKP,etal.Functionsofsurfaceheparansulfateproteoglycans[J].Annu.Rev.Biochem,1999,68:729-777.

OOHIRAA.,MATSUIF.,TOKITAY.,etal.Molecularinterac-tionsofneuralchondroitinsulfateproteoglycansinthebrainde-velopment[J].ArchBiochem.Biophys,2000,374:24-34.XIAOY,KLEEFFJ,SHIX,etal.Heparanaseexpressioninhepatocellularcarcinomaandthecirrhoticliver[J].HepatolRes,2003,26(3):192-198.SATOT,YAMAGUCHIA,GOIT,etal.Heparanaseexpressioninhumancolorectalcanceranditsrelationshiptotumorangio-genesis,hematogenousmetastasis,andprognosis[J].JSurgOncol,2004,87(4):174-181.GOLDSHMIDTO,ZCHARIAE,ABRAMOVITCHR,etal.surfaceexpressionandsecretionofheparanasemarkedlypromotetumorangiogenesisandmetastasis[J].ProcNatlAcadSciUSA,2002,99(15):10031-10036.SMITHTA,IDAMAKANTIN,MARSHALL-NEFFJ,etal.ceptorinteractionsinvolvedinadenoviral-mediatedgenedeliveryaftersystemicadministrationinnon-humanprimates[J].HumGeneTher,2003,14(17):1595-1604.(張蕾編輯liverdiseasemusthavethehistoriesoftakingsomemedicineswhichcanhurttheliver,atthesametimeeosinophilsmightincreasesignificantlyinblood[9,10].Althoughmostdiseaseshavetheirownpathologicalspeciality,whenwethinkitpossiblethatsomepa-tientsaresufferedfromPSC[3],weshouldprefertheERCPinsteadofpercutaneousliverbiopsy.InordertofindoutBuddy-Chiarisyndrome,bothSUVandCTplaymoreimportantrolesthanpathologicalbiopsy.Thosepeoplesufferedfrommalformationofhepaticbloodvessel,SUV,CT,andhepaticangiographycanhelpuscometotherightconclusion[11].Wearesorrytosaythatwecouldnotfindthedefinitereasonsofsomecasesafterhavingdoneasmuchaspossible.Occasionallysomepathologicalreportssuggestthatthereischronichepatitisintheliver,butnoharmfulfactorscouldbefoundincludingviral,alcoholicfac-torsandtoxicdrugandsoon. ing]Wehavenotstudiedthosepatientswith

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論